Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMFIBROZIL vs GEMTUZUMAB OZOGAMICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GEMFIBROZIL vs GEMTUZUMAB OZOGAMICIN: Safety Overview

Metric GEMFIBROZIL GEMTUZUMAB OZOGAMICIN
Total FAERS Reports 1,089 1,817
Deaths Reported 101 454
Death Rate 9.3% 25.0%
Hospitalizations 286 806
Average Patient Age 56.7 yrs 43.7 yrs
% Female Patients 49.9% 48.8%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Northwind Health Company, LLC Wyeth Pharmaceuticals LLC, a subsidia...
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription